These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 33459720)
21. Maternal genotype influences behavioral development of 3×Tg-AD mouse pups. Blaney CE; Gunn RK; Stover KR; Brown RE Behav Brain Res; 2013 Sep; 252():40-8. PubMed ID: 23711927 [TBL] [Abstract][Full Text] [Related]
22. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease. Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531 [TBL] [Abstract][Full Text] [Related]
23. Sex Dimorphism Profile of Alzheimer's Disease-Type Pathologies in an APP/PS1 Mouse Model. Jiao SS; Bu XL; Liu YH; Zhu C; Wang QH; Shen LL; Liu CH; Wang YR; Yao XQ; Wang YJ Neurotox Res; 2016 Feb; 29(2):256-66. PubMed ID: 26707129 [TBL] [Abstract][Full Text] [Related]
24. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease. Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000 [TBL] [Abstract][Full Text] [Related]
25. Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease. Hutton CP; Lemon JA; Sakic B; Rollo CD; Boreham DR; Fahnestock M; Wojtowicz JM; Becker S J Alzheimers Dis; 2018; 64(3):835-857. PubMed ID: 29914019 [TBL] [Abstract][Full Text] [Related]
26. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition. Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788 [TBL] [Abstract][Full Text] [Related]
27. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer's disease. Robison LS; Gannon OJ; Thomas MA; Salinero AE; Abi-Ghanem C; Poitelon Y; Belin S; Zuloaga KL J Neuroinflammation; 2020 Sep; 17(1):285. PubMed ID: 32993686 [TBL] [Abstract][Full Text] [Related]
28. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
29. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway. Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699 [TBL] [Abstract][Full Text] [Related]
30. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease. Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967 [TBL] [Abstract][Full Text] [Related]
31. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD? Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742 [TBL] [Abstract][Full Text] [Related]
32. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
33. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110 [TBL] [Abstract][Full Text] [Related]
34. Toluidine blue O modifies hippocampal amyloid pathology in a transgenic mouse model of Alzheimer's disease. Yuksel M; Biberoglu K; Onder S; Akbulut KG; Tacal O Biochimie; 2018 Mar; 146():105-112. PubMed ID: 29248542 [TBL] [Abstract][Full Text] [Related]
35. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
36. Short-term modern life-like stress exacerbates Aβ-pathology and synapse loss in 3xTg-AD mice. Baglietto-Vargas D; Chen Y; Suh D; Ager RR; Rodriguez-Ortiz CJ; Medeiros R; Myczek K; Green KN; Baram TZ; LaFerla FM J Neurochem; 2015 Sep; 134(5):915-26. PubMed ID: 26077803 [TBL] [Abstract][Full Text] [Related]
37. AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited. Wirths O; Dins A; Bayer TA J Alzheimers Dis; 2012; 28(4):897-904. PubMed ID: 22112547 [TBL] [Abstract][Full Text] [Related]
38. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease. Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598 [TBL] [Abstract][Full Text] [Related]
39. Impairment of nesting behaviour in 3xTg-AD mice. Torres-Lista V; Giménez-Llort L Behav Brain Res; 2013 Jun; 247():153-7. PubMed ID: 23523959 [TBL] [Abstract][Full Text] [Related]
40. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD). Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]